İlhan Öztop
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 16
- Colorectal Cancer Surgical Treatments 9
- Pancreatic and Hepatic Oncology Research 9
- Lung Cancer Research Studies 9
- Research and Theory top 10%
- Leadership and Management top 10%
-
- Lung Cancer Treatments and Mutations 11
- Gastric Cancer Management and Outcomes 8
- Metastasis and carcinoma case studies 8
-
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Co-authors
- Ahmet AlacacıoğluUğur YılmazTuğba YavuzşenArzu YarenHülya EllıdokuzCem TerziAras Emre CandaÖzgül Sağol
- Partner nations
- TürkiyeUnited StatesIceland
In The Last Decade
İlhan Öztop
100 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Oncology 766
- Research and Theory 16
- Leadership and Management 12
- Pulmonary and Respiratory Medicine 303
- Cardiology and Cardiovascular Medicine 175
Countries citing papers authored by İlhan Öztop
This map shows the geographic impact of İlhan Öztop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlhan Öztop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlhan Öztop more than expected).
Fields of papers citing papers by İlhan Öztop
This network shows the impact of papers produced by İlhan Öztop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlhan Öztop. The network helps show where İlhan Öztop may publish in the future.
Co-authorship network
The 25 scholars most cited alongside İlhan Öztop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 1 | |
| 5 | 2019 | 33 | |
| 6 | 2016 | 46 | |
| 7 | 2014 | 45 | |
| 8 | 2014 | 5 | |
| 9 | 2014 | 24 | |
| 10 | 2014 | 7 | |
| 11 | 2014 | 11 | |
| 12 | 2012 | 6 | |
| 13 | 2012 | 18 | |
| 14 | 2011 | 38 | |
| 15 | Complementary-alternative medicine among cancer patients in the western region of Turkey. | 2009 | 33 |
| 16 | [Surgical treatment in non-small cell lung cancer invading to the chest wall (T3) and vertebra (T4)]. | 2007 | 4 |
| 17 | Küçük Hücreli Dışı Akciğer Kanserinde Prognoztik Faktörler | 2007 | 1 |
| 18 | Erken Evre Küçük Hücreli Dışı Akciğer Kanserinde Adjuvan Kemoterapi | 2006 | 1 |
| 19 | 2006 | 30 | |
| 20 | Astım bronşiyale olgularında serum glutatyon peroksidaz, superoksid dismutaz ve malonil dialdehid düzeyleri ve astım şiddeti ile ilişkisi | 2002 | 1 |
About İlhan Öztop
İlhan Öztop is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Lung Cancer Treatments and Mutations (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Colorectal Cancer Surgical Treatments (9 papers), Pancreatic and Hepatic Oncology Research (9 papers), Lung Cancer Research Studies (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Metastasis and carcinoma case studies (8 papers). The work is most often cited by research in Oncology (766 citations), Research and Theory (16 citations) and Leadership and Management (12 citations). İlhan Öztop has collaborated with scholars based in Türkiye, United States and Iceland. Frequent co-authors include Ahmet Alacacıoğlu, Uğur Yılmaz, Tuğba Yavuzşen, Arzu Yaren, Hülya Ellıdokuz, Cem Terzi, Aras Emre Canda, Özgül Sağol, Mehmet Füzün and Selman Sökmen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.